Class III
Terminated
Sankaijo BOTANICAL LAXATIVE (docusate sodium 8.33 mg and sennosides 1.36 mg) tablets, 150-count bottles, Manufactured by SATO PHARMACEUTICAL CO., LTD., 1-5-27 Motoakasaka Minato-KU Tokyo, Japan; SATO PHARMACEUTICAL, INC., 20695 S. Western Ave., Suite 240, Torrance, CA 90501; NDC 49873-404-01.
- Company
- Sato Pharmaceutical Inc.
- Recall Initiated
- October 1, 2019
- Posted
- November 13, 2019
- Recall Number
- D-0303-2020
- Voluntary / Mandated
- Voluntary: Firm initiated
- Quantity
- 17,284 bottles
- Firm Location
- Torrance, CA, United States
Reason for Recall
Subpotent Drug: Formulated amount of sennosides component is less than labelled claim.
Distribution
Nationwide in the USA and Guam and Saipan, Northern Mariana Islands
Lot / Code Info
Lot #: TXWT, Exp 01/20; TXTS, Exp 10/20; AXWS, Exp 10/21
More recalls by Sato Pharmaceutical Inc.
Other recent Class III Drug recalls
Eptifibatide Injection, 75 mg/100 mL vial for weight-adjusted bolus dosing, 1x100 mL Single-dose Via...
Slate Run Pharmaceuticals
· Mar 4, 2026
Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, Rx only, distributed by Unichem Pharmaceutica...
Unichem Pharmaceuticals Usa Inc.
· Feb 18, 2026
parodontax (cetylpyridinium chloride)ACTIVE GUM HEALTH, Mouthwash, Mint. Net Wt 16.9 FL OZ (500 mL),...
Haleon Us Holdings Llc
· Feb 4, 2026
Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceutic...
Novadoz Pharmaceuticals Llc
· Feb 4, 2026
Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd.,...
Cipla Usa, Inc.
· Jan 28, 2026